APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 217 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $40,952,000 | -42.0% | 1,076,548 | +38.8% | 0.05% | -37.0% |
Q2 2023 | $70,646,000 | -24.1% | 775,480 | -45.1% | 0.08% | -27.0% |
Q1 2023 | $93,101,000 | +23.2% | 1,411,479 | -3.4% | 0.11% | +24.7% |
Q4 2022 | $75,582,000 | -22.2% | 1,461,642 | +2.8% | 0.09% | -25.2% |
Q3 2022 | $97,182,000 | +55.3% | 1,421,535 | +2.7% | 0.12% | +70.0% |
Q2 2022 | $62,562,000 | -6.8% | 1,383,507 | +4.7% | 0.07% | +37.3% |
Q1 2022 | $67,149,000 | +9.9% | 1,321,558 | +2.3% | 0.05% | 0.0% |
Q4 2021 | $61,075,000 | +65.4% | 1,291,783 | +15.3% | 0.05% | +64.5% |
Q3 2021 | $36,918,000 | +7.0% | 1,120,090 | +105.3% | 0.03% | +10.7% |
Q2 2021 | $34,487,000 | +37385.9% | 545,674 | +25339.3% | 0.03% | – |
Q1 2021 | $92,000 | -43.9% | 2,145 | -25.1% | 0.00% | – |
Q4 2020 | $164,000 | +90.7% | 2,862 | 0.0% | 0.00% | – |
Q3 2020 | $86,000 | -7.5% | 2,862 | 0.0% | 0.00% | – |
Q2 2020 | $93,000 | – | 2,862 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |